AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 1906258 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefaclor (20 to 40 mg/kg/day in three divided doses for 10 days)
Number of subjects: 117
Study 1906258 — intervention group
Group type: COMPARATOR
Intervention: Penicillin V (50,000 to 100,000 IU/kg/day in three divided doses for 10 days)
Number of subjects: 117
Study 6315646 — intervention group
Group type: EXPERIMENTAL
Intervention: Ordinary wheat bran (20 grams added to diet)
Number of subjects: 10
Study 6315646 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-phytate wheat bran (20 grams added to diet)
Number of subjects: 10
Study 6315646 — intervention group
Group type: COMPARATOR
Intervention: Hospital diet (control group)
Number of subjects: 10
Study 3861184 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional low-fat diet (carbohydrate 56%; fat 25%; vegetable proteins 7%; animal proteins 12% of energy; P/S ratio 1.0)
Number of subjects: 32
Study 3861184 — intervention group
Group type: COMPARATOR
Intervention: Different low-fat diet (69% of energy as carbohydrate, 19% as fat, 7% as vegetable proteins and 5% as animal proteins; P/S ratio 1.3)
Number of subjects: 32
Study 3861184 — intervention group
Group type: EXPERIMENTAL
Intervention: Both diets (cross-over study on 24 patients)
Number of subjects: 32
Study 31350768 — intervention group
Group type: EXPERIMENTAL
Intervention: BDF + Ib (manual brushing/dental flossing + interdental brushes)
Number of subjects: 142
Study 31350768 — intervention group
Group type: EXPERIMENTAL
Intervention: BDF + Oi (manual brushing/dental flossing + oral irrigator)
Number of subjects: 142
Study 31350768 — intervention group
Group type: COMPARATOR
Intervention: BDF (manual brushing/dental flossing only)
Number of subjects: 142
Study 28855344 — intervention group
Group type: EXPERIMENTAL
Intervention: iSMI (internet-based stress management intervention)
Number of subjects: 117
Study 28855344 — intervention group
Group type: COMPARATOR
Intervention: Attention Control (AC)
Number of subjects: 117
Study 27505335 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive atorvastatin (40mg)
Number of subjects: 120
Study 27505335 — intervention group
Group type: COMPARATOR
Intervention: Standard atorvastatin (20mg)
Number of subjects: 120
Study 26414124 — intervention group
Group type: EXPERIMENTAL
Intervention: Cigarette smokers with high pack-year exposure
Number of subjects: 127
Study 26414124 — intervention group
Group type: EXPERIMENTAL
Intervention: Cigarette smokers with low pack-year exposure
Number of subjects: 127
Study 26414124 — intervention group
Group type: COMPARATOR
Intervention: Young onset/atopic cluster
Number of subjects: 127
Study 26414124 — intervention group
Group type: COMPARATOR
Intervention: Nonsmoker/less eosinophilic cluster
Number of subjects: 127
Study 26414124 — intervention group
Group type: COMPARATOR
Intervention: Female/obese cluster
Number of subjects: 127
Study 23402967 — intervention group
Group type: EXPERIMENTAL
Intervention: 10/100 method (10-s break after 100 compressions)
Number of subjects: 63
Study 23402967 — intervention group
Group type: EXPERIMENTAL
Intervention: 10/200 method (10-s break after 200 compressions)
Number of subjects: 63
Study 23402967 — intervention group
Group type: COMPARATOR
Intervention: CCC method (continuous chest compression without a break)
Number of subjects: 63
Study 20571306 — intervention group
Group type: EXPERIMENTAL
Intervention: Carnitine complex
Number of subjects: 45
Study 20571306 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 45
Study 18948811 — intervention group
Group type: EXPERIMENTAL
Intervention: Cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC)
Number of subjects: 50
Study 16832679 — intervention group
Group type: EXPERIMENTAL
Intervention: gemfibrozil 600 mg orally twice daily for 3 days
Number of subjects: 10
Study 16832679 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 10
Study 14563899 — intervention group
Group type: EXPERIMENTAL
Intervention: co-amoxiclav 2000/125 mg twice daily
Number of subjects: 230
Study 14563899 — intervention group
Group type: COMPARATOR
Intervention: co-amoxiclav 875/125 mg three times daily
Number of subjects: 230
Study 11194410 — intervention group
Group type: EXPERIMENTAL
Intervention: Pictures of objects during encoding
Number of subjects: 0
Study 11194410 — intervention group
Group type: COMPARATOR
Intervention: Words denoting objects during encoding
Number of subjects: 0
Study 11194410 — intervention group
Group type: EXPERIMENTAL
Intervention: Recognition of objects encoded as pictures
Number of subjects: 0
Study 11194410 — intervention group
Group type: COMPARATOR
Intervention: Recognition of objects encoded as words
Number of subjects: 0
Study 11194410 — intervention group
Group type: EXPERIMENTAL
Intervention: Semantic encoding specific to pictures
Number of subjects: 0
Study 11194410 — intervention group
Group type: EXPERIMENTAL
Intervention: Task-specific involvement across pictures and words
Number of subjects: 0
Study 9002789 — intervention group
Group type: EXPERIMENTAL
Intervention: Z100
Number of subjects: 120
Study 9002789 — intervention group
Group type: EXPERIMENTAL
Intervention: Herculite XR
Number of subjects: 120
Study 9002789 — intervention group
Group type: EXPERIMENTAL
Intervention: Clearfil Photo Posterior
Number of subjects: 120
Study 9002789 — intervention group
Group type: EXPERIMENTAL
Intervention: Heliomolar RO
Number of subjects: 120
Study 1480807 — intervention group
Group type: EXPERIMENTAL
Intervention: Ivermectin 100 mcg/kg
Number of subjects: 58
Study 1480807 — intervention group
Group type: EXPERIMENTAL
Intervention: Diethylcarbamazine (DEC) 3 mg/kg
Number of subjects: 58
Study 1480807 — intervention group
Group type: EXPERIMENTAL
Intervention: Diethylcarbamazine (DEC) 6 mg/kg
Number of subjects: 58
Study 1480807 — intervention group
Group type: EXPERIMENTAL
Intervention: Diethylcarbamazine (DEC) 3 mg/kg (3 successive semi-annual doses)
Number of subjects: 58
Study 1480807 — intervention group
Group type: COMPARATOR
Intervention: Ivermectin
Number of subjects: 58
Study 1480807 — intervention group
Group type: COMPARATOR
Intervention: Diethylcarbamazine (DEC)
Number of subjects: 58
Study 6529168 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg of trimipramine in the evening
Number of subjects: 428
Study 6529168 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg of trimipramine three times daily
Number of subjects: 428
Study 6529168 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimipramine
Number of subjects: 428
Study 6529168 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 428
Study 31138860 — intervention group
Group type: EXPERIMENTAL
Intervention: Narrowband UVB phototherapy (24 sessions over 8 weeks)
Number of subjects: 20
Study 28549014 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-assisted surgery
Number of subjects: 163
Study 28549014 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic surgery
Number of subjects: 163
Study 27385349 — intervention group
Group type: EXPERIMENTAL
Intervention: Healive
Number of subjects: 400
Study 27385349 — intervention group
Group type: COMPARATOR
Intervention: Havrix
Number of subjects: 400
Study 24643403 — intervention group
Group type: EXPERIMENTAL
Intervention: landiolol
Number of subjects: 200
Study 24643403 — intervention group
Group type: COMPARATOR
Intervention: digoxin
Number of subjects: 200
Study 22987022 — intervention group
Group type: EXPERIMENTAL
Intervention: Atomoxetine 80 mg daily followed by 100 mg daily for 5 days
Number of subjects: 20
Study 22987022 — intervention group
Group type: EXPERIMENTAL
Intervention: Atomoxetine 80 mg
Number of subjects: 20
Study 22987022 — intervention group
Group type: EXPERIMENTAL
Intervention: Atomoxetine 80 mg and 100 mg
Number of subjects: 20
Study 22987022 — intervention group
Group type: EXPERIMENTAL
Intervention: Atomoxetine
Number of subjects: 20
Study 20202633 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive and tailored education
Number of subjects: 0
Study 20202633 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 0
Study 17999227 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative feedback on initial task (picture-matching)
Number of subjects: 66
Study 17999227 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive feedback on initial task (picture-matching)
Number of subjects: 66
Study 17999227 — intervention group
Group type: EXPERIMENTAL
Intervention: Low self-esteem group
Number of subjects: 66
Study 16270222 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-dose clindamycin (600 mg 1 hour before surgery)
Number of subjects: 124
Study 16270222 — intervention group
Group type: COMPARATOR
Intervention: 24-hour clindamycin prophylaxis (600 mg 1 hour before surgery, followed by 300 mg every 6 hours)
Number of subjects: 124
Study 12358676 — intervention group
Group type: EXPERIMENTAL
Intervention: Naloxone (intravenous bolus followed by continuous infusion)
Number of subjects: 20
Study 12358676 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 9697988 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous intravenous (Ci.v.) IL-2, n = 5
Number of subjects: 16
Study 9697988 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous infusions of polyethylene glycol-modified (PEG) IL-2, n = 7
Number of subjects: 16
Study 9697988 — intervention group
Group type: COMPARATOR
Intervention: Anti-viral therapy alone, n = 4
Number of subjects: 16
Study 9697988 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatment arms (Ci.v. IL-2, PEG IL-2, anti-viral therapy)
Number of subjects: 16
Study 9343594 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceptual Maze Test (PMT)
Number of subjects: 8
Study 9343594 — intervention group
Group type: COMPARATOR
Intervention: Motor control (SHAM)
Number of subjects: 8
Study 9343594 — intervention group
Group type: COMPARATOR
Intervention: Rest condition
Number of subjects: 8
Study 2759955 — intervention group
Group type: EXPERIMENTAL
Intervention: Air breathing
Number of subjects: 6
Study 2759955 — intervention group
Group type: EXPERIMENTAL
Intervention: 15% O2 breathing
Number of subjects: 6
Study 2759955 — intervention group
Group type: EXPERIMENTAL
Intervention: 12% O2 breathing
Number of subjects: 6
Study 266407 — intervention group
Group type: EXPERIMENTAL
Intervention: Active immunotherapy (AI)
Number of subjects: 20
Study 266407 — intervention group
Group type: COMPARATOR
Intervention: Maintenance chemotherapy
Number of subjects: 20
Study 31938877 — intervention group
Group type: EXPERIMENTAL
Intervention: Varenicline
Number of subjects: 173
Study 31938877 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 173
Study 31938877 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatment arms
Number of subjects: 173
Study 27810284 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness and gratitude based intervention (4 times a week for 3 weeks)
Number of subjects: 46
Study 27810284 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness and gratitude based intervention
Number of subjects: 46
Study 27810284 — intervention group
Group type: COMPARATOR
Intervention: Control condition (treatment-as-usual)
Number of subjects: 46
Study 26851697 — intervention group
Group type: EXPERIMENTAL
Intervention: 10mg of hydrocortisone
Number of subjects: 80
Study 26851697 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 25078387 — intervention group
Group type: EXPERIMENTAL
Intervention: TIV/AS03
Number of subjects: 192
Study 25078387 — intervention group
Group type: COMPARATOR
Intervention: TIV
Number of subjects: 192
Study 22952691 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based guided self-help problem-solving therapy (PST), consisting of 5 weekly lessons, supported by e-mail
Number of subjects: 45
Study 22952691 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control group (WL)
Number of subjects: 45
Study 21057570 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary tumors with β-catenin expression
Number of subjects: 65
Study 21057570 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced membrane expression of β-catenin
Number of subjects: 65
Study 21057570 — intervention group
Group type: EXPERIMENTAL
Intervention: Cytoplasmic localization of β-catenin
Number of subjects: 65
Study 21057570 — intervention group
Group type: EXPERIMENTAL
Intervention: Membrane β-catenin expression in ALNM
Number of subjects: 65
Study 21057570 — intervention group
Group type: EXPERIMENTAL
Intervention: Re-expression of β-catenin in ALNM
Number of subjects: 65
Study 17365243 — intervention group
Group type: EXPERIMENTAL
Intervention: IR GRE imaging with gadoversetamide (0.2 or 0.3 mmol/kg)
Number of subjects: 43
Study 17365243 — intervention group
Group type: COMPARATOR
Intervention: SSFP imaging
Number of subjects: 43
Study 17365243 — intervention group
Group type: EXPERIMENTAL
Intervention: IR GRE imaging
Number of subjects: 43
Study 17365243 — intervention group
Group type: EXPERIMENTAL
Intervention: Both SSFP and IR GRE techniques
Number of subjects: 43
Study 15127339 — intervention group
Group type: EXPERIMENTAL
Intervention: Miltefosine (2.5 mg/kg per day orally for 28 days)
Number of subjects: 124
Study 15127339 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 124
Study 11868759 — intervention group
Group type: EXPERIMENTAL
Intervention: Telithromycin 800 mg once daily for 5 days (n = 198)
Number of subjects: 395
Study 11868759 — intervention group
Group type: COMPARATOR
Intervention: Penicillin V 500 mg three times daily for 10 days (n = 197)
Number of subjects: 395
Study 9558688 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol (200 mg/day)
Number of subjects: 20
Study 9558688 — intervention group
Group type: EXPERIMENTAL
Intervention: Nadolol (80 mg/day)
Number of subjects: 20
Study 9558688 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 7889960 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefprozil 30 mg/kg/day (b.i.d.)
Number of subjects: 1279
Study 7889960 — intervention group
Group type: COMPARATOR
Intervention: Amoxicillin-clavulanate 40 mg/kg/day (t.i.d.)
Number of subjects: 1279
Study 7889960 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefprozil
Number of subjects: 1279
Study 7889960 — intervention group
Group type: COMPARATOR
Intervention: Amoxicillin-clavulanate
Number of subjects: 1279
Study 7889960 — intervention group
Group type: COMPARATOR
Intervention: Cefaclor 40 mg/kg/day (t.i.d.)
Number of subjects: 1279
Study 7889960 — intervention group
Group type: COMPARATOR
Intervention: Cefixime 8 mg/kg/day (q.d.)
Number of subjects: 1279
Study 3116996 — intervention group
Group type: EXPERIMENTAL
Intervention: Labetalol
Number of subjects: 176
Study 3116996 — intervention group
Group type: COMPARATOR
Intervention: Methyldopa
Number of subjects: 176
Study 30468942 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive training enhancing basic executive skills
Number of subjects: 36
Study 30468942 — intervention group
Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 36
Study 30468942 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive training
Number of subjects: 36
Study 27645350 — intervention group
Group type: EXPERIMENTAL
Intervention: Very-low-fat, plant-based diet
Number of subjects: 61
Study 27645350 — intervention group
Group type: COMPARATOR
Intervention: Wait-listed control group
Number of subjects: 61
Study 24613160 — intervention group
Group type: EXPERIMENTAL
Intervention: Off-pump coronary artery bypass surgery
Number of subjects: 900
Study 24613160 — intervention group
Group type: COMPARATOR
Intervention: On-pump coronary artery bypass surgery
Number of subjects: 900
Study 24613160 — intervention group
Group type: COMPARATOR
Intervention: Comparison of graft patency between off-pump and on-pump
Number of subjects: 900
Study 21732976 — intervention group
Group type: EXPERIMENTAL
Intervention: Vanillin odour exposure
Number of subjects: 20
Study 21732976 — intervention group
Group type: COMPARATOR
Intervention: No vanillin odour exposure (Control)
Number of subjects: 20
Study 19939441 — intervention group
Group type: EXPERIMENTAL
Intervention: Diindolylmethane (DIM) at approximately 2 mg/kg/day for 12 weeks
Number of subjects: 64
Study 19939441 — intervention group
Group type: EXPERIMENTAL
Intervention: Diindolylmethane (DIM)
Number of subjects: 64
Study 19939441 — intervention group
Group type: COMPARATOR
Intervention: Placebo (defatted rice bran)
Number of subjects: 64
Study 17567538 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyglycolide acid and trimethylene carbonate (Seamguard) used (group 1, n = 24)
Number of subjects: 48
Study 17567538 — intervention group
Group type: COMPARATOR
Intervention: No intervention (group 2, n = 24)
Number of subjects: 48
Study 16280438 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 servings/d of carotenoid-rich vegetables and fruit
Number of subjects: 100
Study 16280438 — intervention group
Group type: COMPARATOR
Intervention: 2 servings/d of carotenoid-rich vegetables and fruit
Number of subjects: 100
Study 11986916 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine GITS (osmotic pump)
Number of subjects: 91
Study 11986916 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine slow release microgranules (NMG)
Number of subjects: 91
Study 7586949 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg cimetidine
Number of subjects: 12
Study 7586949 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 mg cimetidine
Number of subjects: 12
Study 7586949 — intervention group
Group type: EXPERIMENTAL
Intervention: 1200 mg cimetidine
Number of subjects: 12
Study 2172934 — intervention group
Group type: EXPERIMENTAL
Intervention: Nedocromil
Number of subjects: 40
Study 2172934 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 208429 — intervention group
Group type: EXPERIMENTAL
Intervention: theophylline-ephedrine combination (theophylline 90 mg, ephedrine 16 mg and phenobarbital 25 mg in an immediate release layer and theophylline 90 mg and ephedrine 32 mg in a sustained release layer)
Number of subjects: 10
Study 208429 — intervention group
Group type: COMPARATOR
Intervention: terbutaline (5 mg three times daily)
Number of subjects: 10
Study 30664472 — intervention group
Group type: EXPERIMENTAL
Intervention: iCanCope app
Number of subjects: 60
Study 27787681 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led sexual rehabilitation intervention
Number of subjects: 20
Study 27488266 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (cognitive-behavioral model, 8 group sessions of 45 min each)
Number of subjects: 342
Study 27488266 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 342
Study 27488266 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 342
Study 23876893 — intervention group
Group type: EXPERIMENTAL
Intervention: TheraBites (group 1)
Number of subjects: 22
Study 23876893 — intervention group
Group type: EXPERIMENTAL
Intervention: Stacked tongue depressors (group 2)
Number of subjects: 22
Study 21128036 — intervention group
Group type: EXPERIMENTAL
Intervention: Iliocapsularis muscle in Group I (dysplastic hips)
Number of subjects: 85
Study 21128036 — intervention group
Group type: COMPARATOR
Intervention: Iliocapsularis muscle in Group II (excessive acetabular coverage)
Number of subjects: 85
Study 21128036 — intervention group
Group type: EXPERIMENTAL
Intervention: Fatty infiltration in Group I (dysplastic hips)
Number of subjects: 85
Study 21128036 — intervention group
Group type: COMPARATOR
Intervention: Fatty infiltration in Group II (excessive acetabular coverage)
Number of subjects: 85
Study 19955953 — intervention group
Group type: EXPERIMENTAL
Intervention: Graduated compression stockings for 6 months
Number of subjects: 14
Study 19955953 — intervention group
Group type: COMPARATOR
Intervention: Best supportive care
Number of subjects: 14
Study 17935764 — intervention group
Group type: EXPERIMENTAL
Intervention: 300-index of reactivity (IR) dose
Number of subjects: 628
Study 17935764 — intervention group
Group type: EXPERIMENTAL
Intervention: 500-index of reactivity (IR) dose
Number of subjects: 628
Study 17935764 — intervention group
Group type: COMPARATOR
Intervention: 100-index of reactivity (IR) dose
Number of subjects: 628
Study 17935764 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 628
Study 15016256 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% metronidazole gel (MG, n=19)
Number of subjects: 63
Study 15016256 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% chlorhexidine gel (CG, n=20)
Number of subjects: 63
Study 15016256 — intervention group
Group type: COMPARATOR
Intervention: Placebo gel (PG, n=24)
Number of subjects: 63
Study 11716994 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous transdermal 17beta‐estradiol 50 mcg/die plus acetate nomegestrolo 5 mg/die sequentially added for 12 days per month (Group A)
Number of subjects: 121
Study 11716994 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous transdermal 17beta‐estradiol 50 mcg/die plus acetate nomegestrolo 2.5 mg/die added every day (Group B)
Number of subjects: 121
Study 11716994 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous transdermal 17beta‐estradiol 50 mcg/die (Group C)
Number of subjects: 121
Study 11716994 — intervention group
Group type: EXPERIMENTAL
Intervention: Tibolone 2.5 mg/die (Group D)
Number of subjects: 121
Study 11716994 — intervention group
Group type: COMPARATOR
Intervention: No medication (Control Group E)
Number of subjects: 121
Study 9426019 — intervention group
Group type: COMPARATOR
Intervention: Atrial pacing (true and false)
Number of subjects: 16
Study 9426019 — intervention group
Group type: COMPARATOR
Intervention: Ventricular pacing (true and false)
Number of subjects: 16
Study 9426019 — intervention group
Group type: EXPERIMENTAL
Intervention: True ventricular pacing
Number of subjects: 16
Study 9426019 — intervention group
Group type: COMPARATOR
Intervention: False ventricular pacing
Number of subjects: 16
Study 8021039 — intervention group
Group type: EXPERIMENTAL
Intervention: Dental gel
Number of subjects: 0
Study 8021039 — intervention group
Group type: COMPARATOR
Intervention: Dentifrices (three types)
Number of subjects: 0
Study 2530547 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefixime 400 mg/day (single daily dose)
Number of subjects: 431
Study 2530547 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefixime 400 mg/day (two divided doses)
Number of subjects: 431
Study 2530547 — intervention group
Group type: COMPARATOR
Intervention: Cefixime (both regimens)
Number of subjects: 431
Study 1190691 — intervention group
Group type: EXPERIMENTAL
Intervention: Vasectomy and irrigation of distal vasa with acid Kystosol solution
Number of subjects: 90
Study 1190691 — intervention group
Group type: COMPARATOR
Intervention: Vasectomy alone
Number of subjects: 90
Study 29470691 — intervention group
Group type: EXPERIMENTAL
Intervention: Whey hydrolysate (WH)
Number of subjects: 27